The pyrimidine moiety is one of the most widespread heterocycles in biologically occurring compounds, such as nucleic acids components (uracil, thymine and cytosine) and vitamin B1. Due to its prebiotic nature to living cells in biodiversity, it is an highly privileged motif for the development of molecules of biological and pharmaceutical interest. This present work deals with the exploration of chemistry and medicinal diversity of pyrimidine which might pave way to long await discovery in therapeutic medicine for future drug design.
INTRODUCTION
Over the years, the heterocyclic compounds have attracted numerous attentions due to their wide applications in medicinal chemistry research. Nitrogen-containing heterocyclic compounds have been prominent even in early studies of chemistry. Heterocyclic compounds are cyclic compounds with at least two different elements as ring members' atoms, the commonest atoms include nitrogen, oxygen and sulphur (Lagoja, 2005) . Heterocycles are in abundance in nature and are very significant in our lives because of their existence in many naturally occurring molecules such as hormones, antibiotics, caffeine etc. (Nagaraj and Reddy, 2007) . The pyrimidine ring is a heterocyclic aromatic compound that occurs widely in nature. Pyrimidines are one of the two most important biological families of nitrogen containing molecules called nitrogen bases. Pyrimidines have been known since their early days as essential components of nucleic acid to their current usage in the chemotherapy of AIDS (Jain et al., 2006) . Furthermore, the prebiotic synthesis of nucleic acid bases is a central issue in the RNA-world hypothesis, one of the main proposals for the origin of life, based on the self-assembly of nucleic acid monomers (Ruiz-Mirazo et al., 2014) . Possible scenarios for the synthesis of nucleic acids are still under debate and despite the abiotic synthesis of several nucleobases, the relevance of these syntheses to the origin of life is not well established (Kakiya et al., 2002) . Pyrimidine core is found as the inner skeleton in the nucleic acid components; uracil, thymine and cytosine. Pyrimidine template and its heterofused derivatives exhibit promising anticoagulant (Saif, 2005) , antitubercular (Trivedi et al., 2008) , antileukemic (Liu et al., 2003) , antimicrobial (Moustafa et al., 2007) , anti-inflammatory (Panda and Chowdary, 2008) , anti-HIV (Meng et al., 2014) , analgesic (Abdelazeem et al., 2014) , anticancer (Antonelli et al., 2014) , antitumoral , anticonvulsant (Paronikyan et al., 2007) , antiplatelet , antifungal Structure of pyrimidine: Pyrimidine has one axis of symmetry along 2, 5-axis as shown in Fig. 1 , but the symmetry is lost upon unequal substitution at 4-and 6-positions. It is π-deficient because of the presence of electronegative N-atoms. Consequently, the electron densities at 2-and 4/6-positions are depleted and these positions become strongly electron loving and are herein referred to as the electrophilic positions. The electron density at 5-position is only slightly depleted; hence the ring therefore retains benzenoid properties at this position, which herein referred to as the benzenoid position (Woodgate et al., 1987) . However, the electron density at the N-atoms is greatly enhanced and the N-atoms constitute the basic and the nucleophilic centers in pyrimidine. It has three difference pairs of bond length and four different bond angles.
Dipole moments of pyrimidine:
Pyrimidine is considered to be polar in nature with an experimentally determined dipole moment ranging between 2.1 and 2.4 D. The theoretically calculated value lied between 2.13 and 2.25 D. This showed a good correlation with the experimentally determined values (Undheim and Benneche, 1996) .
Ionization properties: Pyrimidine in its monoprotonated and diprotonated state has basic pK a of 1.3 and -6.9, respectively, which compares with value of 5.2 for pyridine. The very marked lowering of basicity observed in pyrimidine is attributed to the electronegativity of the second ring nitrogen. Electron-releasing substituents will counteract the electron deficiency of the ring and thereby increase the basicity (Undheim and Benneche, 1996) . The pK a values of pyrimidine derivatives had also been documented in both basic and acidic media. The basic pK a values for 2 (1H)-pyrimidinone, 4 (3H)-pyrimidinone and 5-hydroxypyrimidine, which structures are shown in Fig. 2 , are 2.2, 1.7, 1.8, while their acidic pK a values were 9.2, 8.6 and 6.8, respectively. An extensive compilation and tabulation of acidic and basic pK a values for simple pyrimidines in water at 20-25°C has been published (Undheim and Benneche, 1996; Kappe, 1994) .
Synthesis of pyrimidine Synthesis via [3+3] cycloaddition:
Preparation of pyrimidines is done generally by condensation reaction between a three-carbon compound and compounds having the amidine structure with sodium hydroxide or ethoxide as a catalyst (Rao et al., 2013) . The reaction can be illustrated by the condensation of acetamidine with ethyl acetoacetate, as shown in Fig. 3 , to form 2,6-dimethylpyrimidin-4-ol (Rao et al., 2013) . Biol. Chem., 9 (4): 148-177, 2015 Fig. 4 . Tert-butanol was reported as the suitable solvent for this reaction (Kim et al., 2007) .
Synthesis via intramolecular cyclization initiated by decarboxylation:
Decarboxylation of malic acid with concentrated sulfuric acid formed β-ketoacid which subsequently reacted with urea to produces uracil which was easily converted to pyrimidine via chlorination and hydrogenation processes. This involves an initial decarboxylation of malic acid under the influence of concentrated H 2 SO 4 to afford a β-ketoacid intermediate which upon reaction with urea gave a 2,4-dione ( Fig. 5 ). This was treated with PdCl 3 to produce 4-chloropyrimidine (uracil) which finally undergoes reduction with H 2 /Pd to eventually give the unsubstituted pyrimidine in good yield as shown in Fig. 5 (Rao et al., 2013) .
Synthesis from condensation of amidine-containing substrate:
A common method for the preparation of the fully aromatized pyrimidine skeleton is the condensation of amidine-containing substrates with suitable carbonyl compounds. Among these protocols, α, β-unsaturated carbonyl and 1,3-dicarbonyl compounds are often used. For example, in the search for COX-2-selective inhibitors, Almansa and co-workers synthesized a variety of pyrazolo[1,5-a] pyrimidines by condensing 4,5-disubstituted pyrazole with an array of enones or with 1,3-dicarbonyl derivatives with the pathway shown in Fig. 6 (Almansa et al., 2001) . Synthesis through condensation of malononitrile: According to a review by Gupta et al. (2010) , condensation of malononitrile with amide-bearing group such as formamide or benzamidine has been reported to result in the formation of 4-amino-5-cyano pyrimidine via a versatile intermediate which was presented in the Fig. 7 .
Synthesis from benzimidazole derivatives:
Asobo and co-workers reported a novel synthesis of biologically active pyrimido[1,2-a] benzimidazole from 2-aminobenzimidazole and allenic nitrile in good yields according to equimolar stoichiometry shown in Fig. 8 . Some of these heterocycles showed modest antibiotic and antiarrhythmic properties (Asobo et al., 2001) .
Green synthetic approach to pyrimidine: Based on Fig. 9 , a green and solvent-free threecomponent condensation of 6-[(dimethylamino)methylene amino] uracil, an aldehyde and NH 4 OAc in the presence of HOAc afforded a one-pot synthesis of dihydropyrimido[4,5-d] pyrimidine when heated under reflux (Prajapati et al., 2007) .
Int. J. Biol. Chem., 9 (4): 148-177, 2015 Preparation from chalcone precursor: Reaction of chalcone with thiourea and guanidine hydrochloride in the presence of sodium hydroxide formed the 4,6-disubstituted pyrimidin-2-thiol and 2 amino-4,6-disubstituted pyrimidines respectively as shown in Fig. 10 (Udupi et al., 2005) .
Pyrimidine synthesis by cyclo-condensation from dithioacetal: Pyrimidine-5carboxaldehydes were obtained from cyclo-condensation reaction of α-formylaroylketene dithioacetal with guanidine or benzamidine (Scheme 9), which in turn was obtained from formylation of α-oxoketene dithioacetal with DMF in the presence of POCl 3 in basic medium (Mathews and Asokan, 2007) . The detail is as pictorially described in Fig. 11 . Synthesis from heterogeneous catalytic approach: Silica Supported Sulfuric Acid (SSA) was used as an efficient heterogeneous catalyst in the research efforts of Ajani et al. (2011) , for the reaction of α, β-unsaturated carbonyl (chalcones) with urea to afford substituted mono and bicyclic pyrimidin-2(1H)-ones in good to excellent yields as shown in the Fig. 12 . They established the efficiency of SSA through its re-usability and higher yields with short reaction times than those obtained from conventional refluxing in concentrated hydrochloric acid (HCl).
Synthesis of monastrol via utilization of Lewis acid promoter, Yb(OTf) 3 :
There has been some interest in monastrol, a potentially important chemotherapeutic for cancer which acts as an inhibitor of mitotic kinesin. For instance, Kappe (1994) successfully synthesized racemic monastrol using microwave mediation in 60% yield from 3-hydroxybenzaldehyde, ethyl acetoacetate and thiourea in the presence of PPE. However, Dondoni et al. (2002) improved the synthesis by using Yb(OTf) 3 as the Lewis acid promoter in THF under conventional heating by reflux, as shown in Fig. 13 , to produce monatrol in 95% yield.
Glycosidic residual synthesis of pyrimidine: Sugar residue can be a subunit in the aldehyde, 1,3-dicarbonyl, or urea; consequently, substitution of the dihydropyrimidine (DHPM) ring may occur in one of three places depending on which component originally contains the glycosidic residue (Dondoni et al., 2001) . From the example presented in Fig. 14, hydropyran carbaldehyde was utilized to deliver 1,2,3,4-tetrahydropyrimidine-5-carboxylate derivative as the major product with moderate diastereo-selection (Dondoni et al., 2001) .
Synthesis of pyrimidine by Biginelli reaction:
In addition to modification of the catalyst, several variants of the Biginelli reaction have emerged as viable alternatives. However, each method requires pre-formation of intermediates that are normally formed in the one-pot Biginelli reaction. First, Atwal et al. (1989) reported the reaction between aldol adducts with urea or thiourea in the presence of sodium bicarbonate in dimethyl formamide at 70°C to give 1,4-dihydro pyrimidines. 1,2,3,4-tetrahydropyrimidine was then produced by deprotection of 1,4-dihydropyrimidines ( Fig. 15 ). In some other cases, the reaction can be catalyzed by Lewis acids such as boron trifluoride (Selvam et al., 2012) . Fig. 16 , benzo-fused pyrimidine derivative, 4-cyclohexyl-6-methoxy-2-phenylquinazoline was prepared by the reaction of certain amides, N-(4-methoxyphenyl) benzamide with carbonitriles (cyclohexanecarbonitrile), under electrophilic activation of the amide with 2-chloropyridine and trifluoromethanesulfonic. For the quantitative yield to be obtained, the reaction must be carried out at a controlled temperature of between -78°C and >45°C in the presence of dichloromethane (Movassaghi and Hill, 2006) .
Synthesis by catalytic cyclization of β-formyl enamide:
A novel and efficient synthesis of pyrimidine from β-formyl enamide involved samarium chloride catalysed cyclisation of β-formyl enamides using urea as source of ammonia under microwave irradiation (Fig. 17 ). This procedure is highly efficient for the synthesis of 2,5,6-trisubstituted pyrimidine (Barthakur et al., 2007) . Karpov and Muller (2003) reported the coupling of acid chlorides with terminal alkynes using one equivalent of triethylamine under Sonogashira conditions. They expatiated that subsequent addition of amines or amidinium salts to the intermediate alkynones formed, allowed a straightforward access to enaminones and pyrimidines under mild conditions shown in Fig. 18 and in excellent yields (Karpov and Muller, 2003) . 
Synthesis by cross coupling reaction:

Preparation via sodium salt of propanol derivatives:
Reaction of sodium salt of 3,3-dimethoxy-2-methoxycarbonylpropen-1-ol with different amidinium salts resulted in 2-substituted pyrimidine-5-carboxylic esters by heating under reflux for 1 h in the presence of dimethylformamide (DMF) at a carefully controlled temperature of 100°C as shown in Fig. 19 (Gupta et al., 2010) .
Prebiotic synthesis of pyrimidine:
The isolation of purine and pyrimidine from Murchison meterorite was cited as evidence that these substances might have been present in a prebiotic environment. The first prebiotic synthesis of pyrimidine was the synthesis of cytosine from prop-2ynenitrile (cyanoacetylene) and cyanate as shown in the Fig. 20 (Lagoja, 2005) .
Microwave-assisted synthesis:
An efficient one-pot synthetic method for the highly substituted 5H-[1,3,4]thiadiazolo [3,2-a]pyrimidine-6-carboxylate derivatives was accomplished via microwave irradiation. Microwave-assisted Multi-Component Reaction (MCR) of benzaldehyde, 5-phenyl-1,3,4thiadiazole-2-amine and ethyl acetoacetate in acetic acid without any catalyst afforded ethyl7methyl-2,5-diphenyl-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carboxylate in 85% yield ( Fig. 21 ) (Zhao et al., 2014) .
Synthesis via 1-benzotriazolyl-2-propynones:
A novel 1-benzotriazolyl-2-propynones provided access to the fused ring systems of pyrido[1,2-α]pyrimidin-2-ones and 2H-quinolizin-2-ones, known Biol. Chem., 9 (4): 148-177, 2015 for their diverse biological activities. Reactions of N-(phenylpropioyl)benzotriazole with substituted 2-aminopyridines afforded pyrido[1,2-α] pyrimidin-2-ones in good yields (71-73%) and the byproduct yield was drastically reduced when the reaction was carried out in sealed tube for 12 h as shown in Fig. 22 (Katritzky et al., 2004) .
Synthesis via steroidal ketone:
The preparation of steroid/nonsteroid fused 7-substituted pyrazolo[1,5-a]pyrimidines is described by a one-pot reaction of steroidal/nonsteroidal ketones, aromatic aldehydes and 3-amino-1H-pyrazoles/5-amino-1H-pyrazoles in the presence of potassium tert-butoxide. When anisaldehyde and 3-aminopyrazole were used, steroidal fused 7-substituted pyrazolo [1,5-α] pyrimidine was obtained in 76% as shown in Fig. 23 (Saikia et al., 2014) .
Synthesis via ring transformation of pyran-3-carbonitrile derivatives:
Synthesis of tricyclic pyrimidine chemosensor, BTP-1 was achieved by using a mild base through ring transformation of suitably functionalized 4-(methylthio)-2-oxo-6-naphthyl-2H-pyran-3-carbonitriles with 2-aminobenzothiazole in DMF using DBU as the base as shown in Fig. 24 (Nandre et al., 2014) .
Ice bath synthesis of pyrimidine:
Recent discovery showed that the synthesis of pyrimidines under a methane/nitrogen atmosphere is possible with high yields if a urea source is present. In this process, the presence of frozen water or ice is a decisive factor. With water subjected to freezethaw cycles, the synthesis of pyrimidines and triazines is strongly favored in ice cold condition. The ice matrix plays the role of a protective medium that avoids the degradation of molecules such as the pyrimidines, enhances the yields and diminishes the side reactions, which constitute the constraints for the actual prebiotic relevance of cyanoacetylene, acetylene, or urea (Menor-Salvan et al., 2009 ). Int. J. Biol. Chem., 9 (4): 148-177, 2015 MeS 
Reactions of pyrimidine derivatives
Acylation reaction at nitrogen: Acylation of the ring nitrogen in fully conjugated pyrimidine derivatives led to a pyridimium salt as reported by Cruickshank et al. (1984) . This is achieved by treatment of pyrimidine with ethanoyl chloride in the presence of mineral acid (Fig. 25 ). In similar manner, benzoylation of uracil in the presence of pyridine gives 1-benzoyluracil provided there is limited supply of benzoyl chloride and 1,3-dibenzoyluracil in excess of benzoylating agent as shown in Fig. 25 (Cruickshank et al., 1984) . Selective removal of 1-benzoyl group can be effected under mild basic condition to furnish the 3-benzoyl derivatives (Cruickshank et al., 1984) .
Alkylation reaction at nitrogen: Reactions of electrophiles with annular nitrogen have been reported. Simple alkylations of pyrimidines with non-tautomerizable substituents were largely controlled by steric factors. For instance, 4-t-butyl-6-methylpyrimidin with benzyl chloride in toluene formed exclusively 1-benzylated product as presented in Fig. 26 (Curphey and Prasad, 1972) .
Oxidation at nitrogen: Pyrimidines and methylpyrimidines are susceptible to decomposition, ring-carbon oxidation and ring-opening reactions on direct N-oxidation, resulting in low yields of N-oxides. Activating substituents are required. According to Fig. 27 , with m-chloroper benzoic acid in chloroform, pyrimidine afforded pyrimidine N-oxides in 48% yield whereas when 2-methyl pyrimidine was used as the starting material 2-methyl pyrimidine N-oxides product was obtained in 55% yield as reported by Undheim and Benneche (1996) .
Int. J. Biol. Chem., 9 (4): 148-177, 2015 H Nitration at the carbon: Pyrimidine and its cation are highly π-deficient and resist nitration. The π-system in the 5-nitro derivative is further electron-depleted. Presumably adducts are formed which either are oxidized or ring-opened. Nitration of pyrimidine is a very difficult task. However, aryl substituted pyrimidine are often nitrated preferentially at the aryl. According to Fig. 28 , nitration of 4-phenyl pyrimidine in the presence of a mixture of concentrated nitric and sulphuric acids yielded 40 and 60% of 4-o-nitrophenylpyrimidine and 4-m-nitrophenyl pyrimidine, respectively (Bourguignon et al., 1982) .
Nitrosation at carbon: Nitrosation takes place in the benzenoid 5-position in pyrimidines with three strongly electron-donating groups e.g. oxo, thioxo, or amino groups. In disubstituted pyrimidines, the relative positions of the substituents are decisive for any reaction. According to Fig. 29a-b , 4,6-diamino-and 4,6-dihydroxypyrimidines are 5-nitrosated to give 5-nitrosopyrimidine-4,6-diamine and 5-nitrosopyrimidine-4,6-diol respectively whereas their 2,4-isomers fail to react as shown in Fig. 29c-d . Nitrosation is brought about by nitrous acid or by nitrite esters (Brown et al., 1994) .
Alkoxylation and aryloxylation at carbon: Nucleophilic displacement of 2-and 4/6-halo substituents by alkoxyl or aryloxy ions occurred readily except in the presence of strongly electronreleasing substituents in the ring (Undheim and Benneche, 1996) . In 2-bromo-4-chloro-5ethoxypyrimidine, the chlorine in the more reactive 4-position was selectively substituted during ethanolysis to give 2-bromo-4,5-diethoxypyrimidine as shown in Fig. 30a . Whereas, in the Int. J. Biol. Chem., 9 (4): 148-177, 2015 (Undheim and Benneche, 1996) .
Diazo coupling reaction of pyrimidine:
The diazonium electrophile is weak and requires highly nucleophilic counterparts for reaction. At least, two strong electron-releasing substituents at C2 and C4 (or C6) are needed for pyrimidines to couple at C5. For example, according to Fig. 31 , reaction of 4-amino-2-hydroxypyrimidine with diazonium salt afforded azo dye, 4-amino-5-(phenyldiazenyl) pyrimidin-2-ol in good yield as reported by Brown et al. (1994) .
Halogenation reaction of pyrimidine:
Pyrimidines are halogenated directly by electrophilic reagents in the 5-position. Halogenations in the electrophilic positions are by nucleophilic exchange reactions. Pyrimidine needs to be activated, for example by electron donating group such as a hydroxyl or amino group or 2-tertbutyl, for chlorination to occur in the 5-position. Some of the suitable chlorinating agents that have been used include chlorine in the presence of base; phenyl iododichloride, sulfuryl chloride or thionyl chloride with ferric chloride as catalyst. According to Fig. 31a , the treatment of 4-amino-2-hydroxypyrimidine with sulfuryl chloride in the presence of ferric chloride afforded 4-amino-5-chloro-2-hydroxypyrimidine (Undheim and Benneche, 1996) . However, 4-amino-5-bromo-2-hydroxypyrimidine is formed in 71-78% yield using bromine in solvents like benzene or nitrobenzene (Undheim and Benneche, 1996) as shown in Fig. 32b . 
Reduction of pyrimidine:
The reduction of pyrimidine by NaB(CN)H 3 in methanol, with concurrent trapping of the reduced forms by benzyl chloroformate, was reported to give the dibenzyl pyrimidine-1,3(2H,4H)-dicarboxylate called the pyrimidine enamine (Undheim and Benneche, 1996) as shown in Fig. 33 .
Oxidation of pyrimidine:
The 2-methylgroup side chain of pyrimidine was oxidized to carboxyl group by oxidizing agents such as potassium permanganate in order to obtain pyrimidine-2carboxylic acid as shown in Fig. 34 . A 5-methyl group was difficult to oxidize and an N-methyl group was resistant. Under mild oxidizing conditions, pyrimidine carbaldehydes were formed (Undheim and Benneche, 1996) .
Synthetic applications of pyrimidine derivatives:
Some interesting non-medical applications were found once again for pyrimidines. The first successful prebiotic-related synthesis of a pyrimidine nucleoside from a free base and a non-activated sugar was reported when it was found that drying and heating 2-pyrimidinone and ribose gave the corresponding β-furanosyl ribonucleoside, which structure is shown in Fig. 35 , in about a 12% yield (Bean et al., 2007) . The synthesis and spectroluminescent properties of new 4-oxo-4,6,7,8-tetrahydropyrrolo[1,2a]thieno [2,3-d] pyrimidinium styryls as fluorescent dyes for bimolecular detection were reported (Balanda et al., 2007) . In the presence of RNA, these dyes significantly enhanced emission intensity and might become RNA-specific fluorescent probes.
The nucleophilic substitution reaction of manganocene, Cp 2 Mn, with an equimolar amount of the Li + salt of 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-α]pyrimidine (hppH), with the structure presented in Fig. 35 , affords the neutral dimer [CpMn(hpp)] 2 , further substitution of the Cp ligands has been found to give the unusual dimeric manganate cage compound [LiMn(hpp) 3 ] 2 via dimerization of a trisorganomanganate monomer. A series of biodegradable polymers containing Int. J. Biol. Chem., 9 (4) Fig. 35 , were prepared by first condensing chlorinated poly (lactic acid) or chlorinated poly(lactic acid-coglycolic acid) with potassium sulfadiazine and then with 1,3-dihydroxymethyl-5fluorouracil (Chang et al., 2007) . A one-pot synthesis of 1-benzoyl-2(S)-substituted-5-iodo-2,3dihydro pyrimidin-4(1H)-ones was developed, based on the tandem decarboxylation b-iodination of 6-carboxyhexahydropyrimidin-4-one and these were processed further to give α-substituted bamino acids with high enantioselectivity like (a-c) (Diaz-Sanchez et al., 2007) .
1,3-Dimethyl-5-{(thien-2-yl)-[4-(1-piperidyl)phenyl]methylidene}-(1H,3H)-pyrimidine-2,4,6trione, shown in Fig. 36 which is a new merocyanine dye, was synthesized from 1,3dimethylbarbituric acid and its solvatochromic response in 26 solvents of different polarity was measured (El- Sayed and Spange, 2007) . The adsorption of α-amino acid/5-nitroso-6-oxopyrimidine conjugates onto activated carbon increased its adsorption capacity for Cu 2+ as established by Gutierrez-Valero et al. (2007) . Furthermore, the 2-oxo-and 2-thioxopyrimidines ( Fig. 36) were prepared in a one-pot cyclocondensation of β-ketoester, aldehyde and urea/thiourea using BnNEt 3 Cl as catalyst and under solvent-free conditions (Mobinikhaledi et al., 2007) . Similarly, a successful protocol for the hydrogenation of 4,6-diamino-1H-pyrimidine-2-thione to 4,6-diamino-3,4-dihydro-1H-pyrimidine-2-thione has been reported in zinc dust in the presence of adequate amount of glacial acetic acid (Sayed et al., 2006) .
BIOLOGICAL ACTIVITIES
Antibacterial activity: Andrews and Ahmed (2015) reported 5-(5-amino-1,3,4-thiadiazol-2-yl)-4-(4-hydroxy phenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one to be the most promising antibacterial among the series screened by them. 2-(1,3-benzothiazol-2-ylimino)-1,2-dihydro pyrimidine-4,6diamine excellent activity on both gram positive and negative isolate (Soliman et al., 2014) . Other (Gulcan et al., 2014) , pyrimidine-nucleotide (cGMP-AM) (Beckert et al., 2014) , pyrrolidinyl-pyrimidine (Nguyen et al., 2014) and 5-amino-thiazolo[4,5-d]pyrimidine (Jang et al., 2011) as shown in Fig. 37 .
Antifungal activity: Flucytosine is a pyrimidine-based drug used as an antifungal agent for the treatment of extreme infections like candida and cryptococcus while hexitidine is used to treat primarily aphthous ulceration (Jain et al., 2006) . Efficient antifungal activity of 2-amino-4methoxy-6-substituted thiazolyl pyrimidine reported (Rindhe et al., 2005) . Pyrimidine has largest zones of inhibition against Aspergillus niger (10 mm) and Penicillium sp. (9 mm) among the compounds screened by Faty et al. (2015) . Benzothiazole-pyrimidine was the most active among those tested by Maddila et al. (2013) . According to the structure shown in Fig. 38 , pyrrolo[2,3-d]pyrimidines possessed excellent activity against Candida albicans with MIC 0.31-0.62 mg mLG 1 (Hilmy et al., 2010) (Fig. 2) .
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Antiviral activity:
Recently, pyrimidine-based compounds and derivatives have a wide interest due to their useful antiviral properties. 5-iododeoxyuridine is pyrimidine-based heterocyclic antiviral agents that have been used extensively for the treatment of viral infections (Jain et al., 2006) . 2-(4-methyl-5-nitro-6-(pyrrolidin-1-yl)-pyrimidin-2-ylamino)-3-phenylpropanoic acid (Fig. 39 ) exhibited antiviral activity with IC 50 of 73 μg mLG 1 (Danesh et al., 2015) while 2,4diaminopyrimidine derivative (IC 50 = 13 μg mLG 1 ) was the most effective among the series screened by Fernandez-Cureses et al. (2015) . Other recently reported pyrimidines with promising antiviral activities in Fig. 39 , were 7-(4-methylphenyl)-8,9-diphenyl-7H-pyrrolo[3,2-e] [1,2,4]-triazolo[1,5c]pyrimidine-2-thione (Mohamed et al., 2015a) and 5-(5-(sec-butythio)-1,3,4-thiadiazol-2yl)-2methylpyrimidin-4-amine (Wu et al., 2015) (Fig. 3 ).
Anticancer activity:
Tarceva is a pyrimidine-based cancer drug available in the market. 1,2,3,4tetra hydropyrimidine analogue was found to be potent against various human cancer cell lines (Bari et al., 2015) . Triazolo-pyrimidinone (Mohamed et al., 2015b) and pyrazolo-pyrimidine (Pogorelcnik et al., 2015) with the structures shown in Fig. 40 , revealed promising anticancer activities compared to the activity of the commonly used anticancer drug, doxorubicin in both MCF-7 and A549 cell lines. 4-(2-chlorophenyl)-6-(2,4-dichlorophenyl)pyrimidin-2-amine exhibited remarkable growth inhibition at single dose (10 μM) against lung cancer cell line HOP-92 (Rashid et al., 2014) . 2-[(5-anilino-1,3,4-thiadiazol-2-yl)methyl]-5,6,7,8tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one was reported to show improved activity against lung and breast cancer (Mavrova et al., 2014) (Fig. 40 ).
Antitubercular activity:
Tuberculosis is an infectious disease that is caused by the bacterium Mycobacterium tuberculosis. Capreomycin and viomycin, shown in Fig. 41 , are commercially available pyrimidine-containing antitubercular drugs (Jain et al., 2006) . Deazapurine nucleoside (IC 50 = 0.0012±0.0001 μM) was reported to be highly potent antitubercular pyrimidine (Malnuit et al., 2015) . Imidazo[1,2-c]pyrimidin-4-ol emerged as the most potent among the series screened by Barot et al. (2014) against M. tuberculosis H 37 Rv. According to Shakya et al. (2012) , Fig. 39 : Selected pyrimidine moieties with antiviral activity Int. J. Biol. Chem., 9 (4): 148-177, 2015 Fig. 41 . was the most active with MIC 50 = 0.5 μg mLG 1 . N-(2-fluoro-4-(furan-2-yl)-6-(4-methoxybenzyl amino)pyrimi din-5-yl)form amide inhibited the growth of M. tb H 37 Rv at IC 90 <0.2 μg mLG 1 and also exhibited low toxicity towards mammalian cells as reported by Read et al. (2010) .
Antitumor activity: Pyrrolo[2,3-d]pyrimidines with folate receptor was identified by Wang et al. (2015) as potential antitumor compound. Abbas et al. (2015) reported 4-(4-fluorophenyl)-6-oxo-2- [(1-Int. J. Biol. Chem., 9 (4): 148-177, 2015 henyl-1H-pyrazolo [3,4-d] pyrimidin-4-yl)thio]-1,6-dihydropyrimidine-5-carbonitrile, showed in Fig. 42 , to be promising antitumor because it exhibited also high inhibition (91%) against EGFR-TK. 2-(5-cyano-2-(prop-2-yn-1-ylthio)-6-(3,4,5-trimethoxyphenyl) -pyrimidin-4-yl) hydrazine carbothioamide showed marked inhibition of cell migration and in vivo tumor suppressing and antimetastasis (Ma et al., 2015) . 1-(4-chlorophenyl)-3-(4-(4-((3-(diethylamino)propyl)amino) thieno[3,2-d]pyrimidin-2-yl)phenyl)urea showed antitumor activities with IC 50 values of 0.081 μM, 0.058 μM, 0.18 μM and 0.23 μM against H460, HT-29, MKN-45 and MDA-MB-231 cell lines (Liu et al., 2014a) (Fig. 42 ). -phenyl-1H-pyrazolo[3,4-d] pyrimidin-4yl]acetohydrazide, screened via acetic acid induced writhing test, showed good analgesic activity (Raj et al., 2006) . 1-((5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl)methyl)-2-((pyrimidin-2-ylthio)methyl)-1H-benzo [d] imidazole showed in Fig. 43 , was a selective COX-2 inhibitor with IC 50 8.2 mM as well as promising anti-inflammatory agent (68.4%) while 1-((5-ethyl-1,3,4-oxadiazol-2-yl)methyl)-2-(pyrimidin -2-ylthio)methyl)-1H-benzo [d] imidazole has dual action as anticancer and anti-inflamm atory pyrimidine (Rathore et al., 2014) . According to Sharma et al. (2014), N-(4-hydroxy -6-tosyl-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidin-2-yl)-4-nitrobenzamide (IC 50 = 254 μM) and N- (4-hydroxy-6-tosyl-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidin-2-yl)isonicotin amide (IC 50 = 231 μM) exhibited good analgesic and anti-inflammatory profiles and proved effective in the treatment of neuropathic pain. 5-(2-(Azepan-1-yl)ethyl)-1-phenyl-1H-pyrazolo [3,4-d] pyrimidin-4(5H) -one showed in Fig. 43 , was reported to be more active than ketorolac standard drug, hence, cloud be developed into anti-inflammatory/analgesic drug with the probability of fewer side effects (Abdelazeem et al., 2014) ( Fig. 7 ).
Analgesic and anti-inflammatory activity: 2-[Chloro
Antimalarial activity: N , N ' -(4,4'-(Furan-2,5-diyl)bis(3,5-diisopropoxy-4,1phenylene))dipyrimidine-2-carboxim idamide with structure in Fig. 44 , showed good activity against P. falciparum at IC 50 of 8.5 nM (Liu et al., 2014b) . Pyrimidine-based anti-malarial drugs available in the market include perimethamine, sulfadiazine and trimethoprim. However, more efforts have been developed in antimalarial drug research because of drug resistance problem.Thus, hybrids of 4-aminoquinoline, N 1 -(7-chloroquinolin-4-yl)-N 3 -(4-(piperidin-1-yl)pyrimidin-2yl)propane-1,3-diamine screened by Singh et al. (2014) and N 1 -(7-chloroquinolin-4-yl)-N 2 -(6-methyl-Int. J. Biol. Chem., 9 (4): 148-177, 2015 Cl Manohar et al. (2012) showed antiplasmodial activity in nM range against chloroquine-resistant and chloroquinesensitive strains of Plasmodium falciparum (Fig. 44) .
Anti-HIV activity:
The Human Immunodeficiency Virus (HIV) is a virus that attacks the immune system. 4-((4-((4-(2,6-dichlorobenzyl)-5-methyl-6-oxo-1,6-dihydropyrimidin-2-ylthio)methyl)-1H-1,2,3-triazol-1-yl)methyl) benzenesulfonamide (Fang et al., 2015) and 3,4-dihydro-2H,6H-Int. J. Biol. Chem., 9 (4): 148-177, 2015 H (Okazaki et al., 2015a) , shown in Fig. 45 , exhibited strong HIV-1 inhibitory potency at EC 50 of 3.22, 0.30 and 0.29 μM, respectively. Chemical transformation of this isothiazolo-was achieved later to produce 2-(2-mercaptophenyl)-1,4,5,6tetrahydropyrimidine ( Fig. 45 ) which was un veiled as an active anti-HIV moiety with promising feature (Okazaki et al., 2015b) . 4-((7-(Mesitylamino)-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)amino) benzonitrilewas discovery as potent HIV-1 NNRTIs using a structure-guided core-refining approach . Other promising anti-HIV pyrimidine established through research efforts include 2-(4-cyanophenylamino)-4-(2-cyanovinylphenylhydrazonomethyl)pyrimidine (Meng et al., 2014) and 4-(7-(mesityloxy)pyrazolo[1,5-α]pyrimidin-5-ylamino)benzonitrile which structures were shown in Fig. 45 .
Antiplatelet activity: Current anti-platelet drugs are important for the prevention and treatment of acute ischemic syndromes. Discovery of N-(2-hydroxyethyl)-N-methyl-2-morpholino-4oxo-9-(1-phenoxyethyl)-4H-pyrido[1,2-a]pyrimidine-7-carboxamide shown in Fig. 46 , as oral PI3Kb inhibitors which was useful as antiplatelet agent was reported by Giordanetto et al. (2014) (Okuda et al., 2014b) presented in Fig. 46 , as promising anti-platelet candidates with potencies superior to aspirin.
Kinase inhibitory activity: 2-(4-methoxyphenyl)-5-methyl-N-(4-methylphenyl)[1,3]oxazolo[5,4d]pyrimidin-7-amine strongly inhibited VEGFR-2 kinase and HUVEC with IC 50 values of 0.33 and 0.29 μM (Deng et al., 2015) . (R)-5-chloro-N 2 -[4-(4-methylpiperazin-1-yl)phenyl]-N 4 -[(tetra hydrofuran-2-yl)methyl]pyrimidine-2,4-diamine presented in Fig. 47 , was developed as novel ACK1/TNK2 inhibitors using a fragment-based approach (Lawrence et al., 2015) . 1-(2-(4bromo phenyl)-2-chloroethyl)-N-(2-chlorobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine showed in Fig. 47 , was reported as a SRC family kinase inhibitor which could be a feasible approach for glioblastoma treatment (Ceccherini et al., 2015) .
Antiamoebic activity: Amoebiasis, the most aggressive disease of the human intestine, is caused by the anaerobic protozoan parasite Entamoeba histolytica (Lejeune et al., 2009) . Out of sixteen compounds evaluated against HM1: IMSS strain of Entamoeba histolytica by Parveen et al. (2010) , 4-(4-chlorophenyl)-6-ferrocenyl-2-piperidin-1-yl-pyrimidine with the structure showed in Fig. 48 , was found most active and least toxic among all the compounds. From the in silico molecular docking simulation investigated by Yadava et al. (2015) , 1-(4-amino-3-phenyl-1H-pyrazolo[3,4d]pyrimidin-1-ylsulfonyl)-N-p-tolylme thanamide (IC 50 = 0.68 μg mLG 1 ), represented in Fig. 48 , was found to be more efficient than the metronidazole drug standard (IC 50 = 1.80 μg mLG 1 ) against the same Entamoeba histolytica. (Thore et al., 2015) . The result showed that 1-isopropyl-4-(4-methylphenyl)- 6,7,8,9-tetrahydro[1,2,4] triazolo[4,3-a]benzo(b)thieno[3,2e]pyrimidin e-5(4H)-one, 4-(4-methylphenyl)-1-pyrrolidin-1- ylmethyl-6,7,8,9-tetrahydro[1,2,4] triazo lo[4,3-a]benzo(b)thieno[3,2-e]pyrimidine-5(4H)-one and 4-(4-methylphenyl)-1-piperidin-1- ylmethyl-6,7,8,9-tetrahydro[1,2,4] triazolo[4,3-a]benzo(b)thieno[3,2-e]pyrimidine-5-(4 H)-one with the presented structures in Fig. 49 , exhibited promising activities, which are comparable to the standard (Thore et al., 2015) .
Herbicidal activity: Assay of a series of pyrimidine scaffolds designed by Cheng et al. (2015) for herbicidal activities revealed that 5-(4-chloro-2-fluoro-5-(prop-2-yn-1-yloxy)phenyl)-1,7-dimethyl-1H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione, with the structure shown in Fig. 50 , exhibited significant herbicidal efficacy. 2-methyl-4-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-6-(prop-2yn-1-yloxy)py rimidine exhibited excellent inhibition activities against weed root growth (Ma et al., 2014a) . Most of the pyrimidines synthesized by Ma et al. (2014b) expressed bleaching activities with 4-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)-6-(prop-2-ynyloxy)pyrimidine, presented in Fig. 50 , showing the best bleaching activity to gramineous weeds. It produced the highest inhibition of chlorophyll level in seedlings of Pennisetum alopecuroides L. Biol. Chem., 9 (4): 148-177, 2015 
CONCLUSION
The synthetic utility of pyrimidines as precursors and valuable intermediates for the successful design of diverse biologically active compounds has given impetus to these studies. Owing to widespread application of pyrimidine in medicinal chemistry research and its occurrence in many biological entities valuable to life, tremendous amount of literature have be accumulated and documented over the years. We have herein reviewed recent advances in the chemistry and biology of pyrimidine in order to provide valuable information on how this scaffold could be used to develop new drugs and bioactive motifs for effective fight against drug resistance which is an emerging bottleneck in pharmaceutical research.
